Company news
Optiscan Imaging Limited news in 2016
Optiscan Imaging Limited's news releases, calls and decks from 2016, newest first.
Cleansing Prospectus
December 27, 2016
Prospectus - Share and Option Issues approved at AGM
December 21, 2016
Share Placement
December 20, 2016
Pre-clinical research product launch
November 22, 2016
Receipt of R&D tax rebate incentive
November 8, 2016
Preliminary Final Report- Appendix 4E
August 31, 2016
Update on cooperation with Carl Zeiss Meditec
August 21, 2016
Reinstatement to Official Quotation - 22 August 2016
August 19, 2016
Shares issued 19 August 2016 and request for reinstatement
August 19, 2016
Chief Executive Officer Appointment
June 10, 2016
New funding for optiscan
March 30, 2016
Zeiss Neurosurgery Purchase Order
March 30, 2016
Shareholder Update June 2012
March 30, 2016
$2M Funding from Bergen Global Opportunity Fund, LP
March 30, 2016
Zeiss Milestones Actualised
March 30, 2016
Update, Capital Raise and Appendix 4E
March 30, 2016
Trading Halt Request
March 30, 2016
Optiscan in Clinical Study at St Vincents Sydney
March 30, 2016
New Funding Facility and Operations Update
March 30, 2016
Optiscan Receives R&D Tax Incentive, Loan Repaid
February 11, 2016
Optiscan Zeiss Collaboration Update
February 10, 2016
Optiscan Appendix 4E and Financial Statements
February 10, 2016
Non-Renounceable Issue
February 10, 2016
New US Patent for Optiscan
February 10, 2016
New Global Supply Agreement
February 10, 2016
March Quarter 2010 Update
February 10, 2016
Major Step in Zeiss Product Development
February 10, 2016
Major Milestone Recognised
February 10, 2016
Half Yearly Report and Accounts
February 10, 2016
Global Launch of CellLIVe in Hawaii, USA
February 10, 2016
Funding and Update
February 10, 2016
CellLIVE Update
February 10, 2016
Board Changes at Optiscan
February 10, 2016
Board Changes and Funding Update
February 10, 2016